Literature DB >> 35175942

Systemic Vasculitis Following SARS-CoV-2 mRNA Vaccination Demonstrated on FDG PET/CT.

Koya Nakatani1, Etsuro Sakata1, Masakazu Fujihara2, Kaoru Mizukawa3, Takashi Koyama1.   

Abstract

ABSTRACT: Causality regarding adverse events following SARS-CoV-2 mRNA vaccine is undetermined for vasculitis. Herein, we report the case of an 80-year-old man who presented with a persistent high fever of 7 days' duration that began shortly after receiving a COVID-19 vaccination. There was also a complaint of persistent lower limb pain and walking difficulty on emergency transportation. FDG PET/CT demonstrated extensive linear hypermetabolic foci along the vessels of both legs, including the hips, and the arms, supraclavicular area, chest wall, and temporal regions, suggesting systemic vasculitis. Subsequent temporal artery biopsy revealed arteritis, which is not typical of giant cell arteritis.
Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35175942      PMCID: PMC8983613          DOI: 10.1097/RLU.0000000000004115

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN: 0363-9762            Impact factor:   7.794


An 80-old-year man was referred to our emergency room owing to a high fever lasting 7 days, with walking difficulty. He had received a second SARS-CoV-2 mRNA vaccination 1 week earlier, and the onset of fever >39°C began the day after the vaccination. He also had persistent lower extremity pain beginning 3 days after immunization. Laboratory data at admission were as follows: white blood cell count, 17,300 cells/μL; lactate dehydrogenase, 662 U/L; and C-reactive protein, 31.9 mg/dL. He underwent FDG PET/CT to identify an inflammatory focus. Extensive linear and patchy hypermetabolic foci along the major vessels and their branches, including medium-sized arteries, such as the muscular or distributing arteries, were observed in both legs and hips (A: MIP, C: coronal fusion), arms, supraclavicular area, chest wall (D, arrow), and temporal regions (B, arrow). Left axillary node swelling after vaccination was also observed (D, arrowhead). Femoral MRI (E) was performed because subcutaneous panniculitis was initially considered a differential diagnosis. High-intensity signals in the artery wall and perivascular connective tissues were observed mainly in the quadriceps muscles, suggesting lower limb vasculitis or small vessel vasculitis. However, muscle biopsy failed to show pathognomonic findings. The utility of FDG PET/CT in large vessel vasculitis (i.e., Takayasu arteritis and giant cell arteritis [GCA]) has been established.[1,2] However, the characteristics in this case differed from the characteristics of Takayasu arteritis and GCA; no significant accumulation or vessel wall thickening was observed in the aortic wall and its major branches (A). The findings in our case resembled the “ant farm”–like appearance reported with restricted lower vasculitis.[3] Muscle biopsies are not absolute, when determining a vasculitis diagnosis, and false-negative results are not uncommon. Interestingly, this case had a more extensive anatomical range of abnormalities, such as the temporal regions and part of the trunk. There was abnormal FDG uptake in the temporal artery, which was the region where the patient complained of a headache. Accordingly, ultrasonography of the temporal arteries (A) was performed. Arterial wall thickening was observed (arrows), but it was brighter than the typical “dark halo” sign of GCA. Subsequently, temporal artery biopsy (B) was performed. Histological examination revealed neutrophil and lymphocyte infiltration mainly on the internal and external elastic plates where some of the vascular wall structure had been markedly destroyed; however, no giant cell formation was observed. These findings were not suggestive of GCA, but rather of an acute onset of unexplained systemic vasculitis. It has become clear that COVID-19 can affect any organ, including the circulatory system, and COVID-19–associated vasculitis is a specific feature of virus-induced systemic disease.[4] There are anecdotal reports that vasculitis occurred following COVID-19 mRNA vaccination.[5-8] However, no causal relationship was identified in any of the reports, and there is no consistency regarding the characteristics of the reported cases. In the present case, as well, it cannot be ruled out that preexisting asymptomatic vasculitis might have coincidentally worsened after vaccination. Therefore, we must remain cautious regarding concluding a causal relationship between systemic vasculitis and the COVID-19 vaccine. Nevertheless, FDG PET helps to assess the characteristic distribution to make a differential diagnosis of vasculitis.
  8 in total

1.  COVID-19 Recombinant mRNA Vaccines and Serious Ocular Inflammatory Side Effects: Real or Coincidence?

Authors:  Arash Maleki; Sydney Look-Why; Ambika Manhapra; C Stephen Foster
Journal:  J Ophthalmic Vis Res       Date:  2021-07-29

Review 2.  Large vessel vasculitis: imaging standards of 18F-FDG PET/CT.

Authors:  Ukihide Tateishi; Junichi Tsuchiya; Kota Yokoyama
Journal:  Jpn J Radiol       Date:  2020-10-27       Impact factor: 2.374

Review 3.  COVID-19-associated vasculitis and vasculopathy.

Authors:  Richard C Becker
Journal:  J Thromb Thrombolysis       Date:  2020-10       Impact factor: 2.300

4.  Leukocytoclastic vasculitis flare following the COVID-19 vaccine.

Authors:  Stephanie R Cohen; Lisa Prussick; Jared S Kahn; David X Gao; Arash Radfar; David Rosmarin
Journal:  Int J Dermatol       Date:  2021-04-30       Impact factor: 3.204

5.  Vasculitis and bursitis on [18F]FDG-PET/CT following COVID-19 mRNA vaccine: post hoc ergo propter hoc?

Authors:  Jan-Henning Schierz; Christine Merkel; Thomas Kittner; Farzana Ali
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-09-08       Impact factor: 9.236

6.  ANCA-Associated Vasculitis Following the Pfizer-BioNTech COVID-19 Vaccine.

Authors:  Muhammad Tariq Shakoor; Mark P Birkenbach; Matthew Lynch
Journal:  Am J Kidney Dis       Date:  2021-07-16       Impact factor: 8.860

Review 7.  FDG-PET/CT(A) imaging in large vessel vasculitis and polymyalgia rheumatica: joint procedural recommendation of the EANM, SNMMI, and the PET Interest Group (PIG), and endorsed by the ASNC.

Authors:  Riemer H J A Slart
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-04-11       Impact factor: 9.236

8.  The "Ant-farm"-like Appearance of Restricted Lower Limb Vasculitis on Fluorodeoxyglucose-positron Emission Tomography.

Authors:  Shintaro Yamamoto; Tomoyuki Mukai; Shunichi Fujita; Yuka Koide; Yumika Ono; Masayuki Inubushi; Hirotake Nishimura; Asami Munekane; Yoshitaka Morita
Journal:  Intern Med       Date:  2021-08-31       Impact factor: 1.271

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.